TL;DR
This study analyzed whole exome sequences from over 5,400 individuals with congenital heart disease (CHD), revealing that rare recessive genetic variants contribute to at least 2.2% of cases. The findings highlight the importance of recessive inheritance, particularly in specific CHD subtypes like laterality defects, and identify novel candidate genes, offering a deeper understanding of CHD's complex genetic architecture.
What Problem Does This Paper Address?
Congenital heart disease (CHD) is a major cause of birth defects, affecting about 1 in 100 newborns. While we know that genetic factors play a significant role, the precise genetic underpinnings of CHD are still not fully understood. Historically, research has focused on dominant genetic mutations or large chromosomal abnormalities. However, there's a growing recognition that recessive genetic contributions, where an individual inherits two copies of a faulty gene, are also important, especially in families with consanguinity. Anecdotal evidence and candidate gene studies have hinted at this, but a comprehensive, large-scale analysis to quantify the overall burden and identify specific genes involved in recessive CHD was lacking. This paper aims to fill that gap by systematically investigating the role of rare, damaging recessive genotypes (RGs) across a large cohort of CHD patients.
Methods
The researchers employed whole exome sequencing (WES) on a large cohort of 5,424 unrelated CHD probands, including trios (proband and both parents) and singletons. They also used WES data from 1,798 control individuals (siblings of probands with autism).
Key analytical steps included:
- Variant Calling and Filtering: Standard WES pipelines were used to identify genetic variants. A crucial step was defining "rare damaging recessive genotypes" (RGs) as variants with a minor allele frequency below 10⁻³ in population databases (gnomAD and Bravo) and predicted to be either loss-of-function (LoF) or damaging missense (D-mis).
- Recessive Genotype Identification: For trios, homozygous and compound heterozygous RGs were directly identified. For singletons, a "variant co-occurrence tool" was used to infer compound heterozygous RGs by identifying variants in the same gene that were likely in trans (on different chromosomes).
- Gene Enrichment Analysis: A binomial test was used to determine if RGs were significantly enriched in known human recessive CHD genes compared to what would be expected by chance. This analysis was adjusted for factors like de novo mutability and consanguinity.
- Genome-Wide Analysis: To identify novel candidate genes, a genome-wide analysis was performed using the same binomial test approach to find genes with statistically significant enrichment of damaging RGs.
- Single-Cell RNA-Seq Analysis: To understand the biological context of identified genes, single-cell RNA sequencing data from mouse gastrulation-stage embryos were used to examine gene expression patterns in different cell types, particularly focusing on notochord and cardiomyocyte lineages.
- Consanguinity Assessment: The inbreeding coefficient was calculated for probands and controls to assess the impact of consanguinity on RG burden.
Datasets
- CHD Proband Cohort: 5,424 unrelated individuals with congenital heart disease (CHD) recruited through the NHLBI Bench-to-Bassinet Program (Pediatric Cardiac Genomics Consortium and Pediatric Heart Network). This cohort included 3,716 parent-offspring trios and 1,708 singleton probands.
- Control Cohort: 1,798 unaffected siblings of individuals with autism from the Simons Simplex Collection (SSC).
- Population Databases: gnomAD and Bravo databases were used for allele frequency filtering of variants.
- Mouse Gastrulation Single-Cell RNA-Seq Data: Data from Pijuan-Sala et al. (2019) were utilized to study gene expression patterns in embryonic development.
Key Insights and Ideas
- Recessive Inheritance is a Significant Contributor: The study firmly establishes that recessive genetic variants are not just rare occurrences but contribute to a measurable percentage (estimated 2.2%) of CHD cases, challenging the historical focus on dominant mutations.
- Laterality Defects are Particularly Enriched for Recessive Causes: The finding that laterality-associated CHD phenotypes show a significantly higher enrichment of RGs (5.4%) compared to other CHD subsets (1.4%) points to specific genetic pathways involved in establishing left-right asymmetry being particularly sensitive to recessive disruption.
- Consanguinity Dramatically Increases Risk: Probands from consanguineous unions had a substantially higher burden of RGs in known CHD genes (4.7% vs. 0.7% in non-consanguineous probands), underscoring the importance of studying these populations for uncovering recessive disease genes.
- Founder Variants Play a Key Role in Specific Populations: The identification of founder variants in GDF1 and PLD1 in the Ashkenazi Jewish population, accounting for a large proportion of their recessive CHD burden, highlights how population-specific genetic history can significantly influence disease prevalence.
- Novel Candidate Genes Identified: The genome-wide analysis pinpointed C1orf127 as a novel gene significantly enriched for RGs, particularly in individuals with laterality defects. Its role in the embryonic notochord suggests a link to left-right patterning.
- Cardiomyocyte Function is Crucial: The enrichment of RGs in genes highly expressed in cardiomyocytes, such as MYH6, UNC45B, MYO18B, and MYBPC3, in probands with left-sided CHD, strongly suggests that impaired contractile function of heart muscle cells is a key mechanism underlying these malformations.
Key Results
- Rare damaging recessive genotypes (RGs) are estimated to contribute to at least 2.2% of all CHD cases.
- Laterality phenotypes showed a higher enrichment of RGs (5.4%) compared to other CHD subsets (1.4%).
- Among 108 curated human recessive CHD genes, 66 contained RGs in the cohort.
- Probands from consanguineous unions had a 6.5-fold higher rate of RGs in known CHD genes compared to non-consanguineous probands.
- 66 damaging RGs were found in known human recessive CHD genes, representing a 3.9-fold enrichment over expectation.
- Genes with significant RG burden accounted for 1.3% of all probands.
- The gene C1orf127 was identified with genome-wide significant enrichment of RGs, particularly associated with laterality defects.
- Founder variants in GDF1 and PLD1 accounted for 74% of the RG contribution in Ashkenazi Jewish probands.
- Genes highly expressed in cardiomyocytes (MYH6, UNC45B, MYO18B, MYBPC3) showed enrichment of RGs in left-sided CHD probands.
Limitations and Future Work
- Variant Interpretation: The authors acknowledge that tools for distinguishing damaging from benign missense variants have limitations, which can affect sensitivity and specificity. This is particularly relevant for clinical application.
- Control Cohort Differences: While efforts were made to match controls, minor differences in ethnic distribution and sequencing metrics exist, though the authors argue these did not impact the gene discovery analysis.
- Incomplete Understanding of Recessive Contribution: While the study quantifies the contribution of known and novel recessive genes, it's estimated that a significant portion (~0.8% of probands, or ~45 individuals) have RGs in genes not yet identified as CHD genes, indicating that many more recessive CHD genes remain to be discovered.
- Future Directions: The authors suggest that future efforts should focus on sequencing larger CHD cohorts, especially those from consanguineous unions and founder populations, to maximize the discovery of new recessive risk genes and mechanisms. They also highlight the potential for these findings to guide genetic testing and personalize patient management. The study also implies that understanding the role of noncoding variants and oligogenic models will be crucial for a complete picture of CHD genetics.
Summary updated